Chronic Graft Versus Host Disease in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant: Analysis of Risk Factors, Pattern and Long Term Outcome-Reference-Cited by-同舟云学术

Chronic Graft Versus Host Disease in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant: Analysis of Risk Factors, Pattern and Long Term Outcome

Published:2015-01-20 Issue:1 Volume:32 Page:32-38
ISSN:0971-4502
Container-title:Indian Journal of Hematology and Blood Transfusion
language:en
Short-container-title:Indian J Hematol Blood Transfus

Author:

Punatar Sachin,Gupta Alok,Gawande Jayant,Bagal Bhausaheb,Mathew Libin,Kannan Sadhana,Khattry Navin

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12288-015-0506-5.pdf

Reference15 articles.

1. Ratanatharathorn V, Ayash L, Lazarus HM, Fu J, Uberti JP (2008) Chronic graft-versus-host disease: clinical manifestation and therapy. Bone Marrow Transpl 28:121–129

2. Zecca M, Prete A, Rondelli R, Lanino E, Balduzzi A, Messina C et al (2002) Chronic graft-versus-host disease in children: incidence, risk factors, and impact on outcome. Blood 100:1192–1200

3. Lee SJ, Vogelsang G, Flowers ME (2003) Chronic Graft-versus-Host Disease. Biol Blood Marrow Transpl 9:215–233

4. Atkinson K, Horowitz MM, Gale RP, van Bekkum DW, Gluckman E, Good RA et al (1990) Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 75:2459–2464

5. Mohty M, Bay JO, Faucher C, Choufi B, Bilger K, Tournilhac O et al (2003) Graft-versus-host disease following allogenic transplantation from HLA-identical sibling with anti thymocyte globulin-based reduced-intensity preparative regimen. Blood 102:470–476

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low levels of CD26 on certain cellular subtypes of donor harvest is associated with better clinical outcomes post allogeneic stem cell transplantation through regulation of NF-κB pathway and pro-inflammatory cytokines;International Immunopharmacology;2023-12

2. Comparison of Outcomes of Donor Lymphocyte Infusions With or Without Lenalidomide in Patients with Hematological Malignancies Post Allogeneic HSCT;Indian Journal of Hematology and Blood Transfusion;2022-07-22

3. CD26 expression on donor harvest as a risk predictive biomarker for developing Graft-versus-Host Disease post-Allogeneic Hematopoietic Stem Cell Transplantation: A tenyear followup study;Cancer Biomarkers;2021-07-23

4. Occurrence and Severity of Donor Lymphocyte Infusion–Associated Chronic Graft-versus-Host Disease Influence the Clinical Outcomes in Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation;Biology of Blood and Marrow Transplantation;2019-05

5. Allogeneic hematopoietic stem cell transplantation for relapsed acute myeloid leukemia in ETO positive with reduced-intensity conditioning;Oncotarget;2017-11-03